These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8901446)

  • 1. Platelet and endothelial cell function in patients with insulin-dependent diabetes mellitus with excellent, good, or poor metabolic control.
    Wagner B; Fasching P; Schneider B; Kurzemann S; Waldhäus W; Lechner K; Kyrle PA
    Microvasc Res; 1996 Sep; 52(2):183-7. PubMed ID: 8901446
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endothelium condition and platelet aggregation in patients with newly diagnosed type 1 diabetes mellitus and undifferentiated connective tissue dysplasia].
    Gladkikh NN; Iagoda AV
    Klin Med (Mosk); 2009; 87(5):52-5. PubMed ID: 19565829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors.
    Dernbach E; Randriamboavonjy V; Fleming I; Zeiher AM; Dimmeler S; Urbich C
    Basic Res Cardiol; 2008 Nov; 103(6):572-81. PubMed ID: 18604625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
    Sørensen VR; Mathiesen ER; Clausen P; Flyvbjerg A; Feldt-Rasmussen B
    Diabet Med; 2005 Jul; 22(7):871-6. PubMed ID: 15975101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
    Blann AD; Lip GY
    Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet cNOS activity is reduced in patients with IDDM and NIDDM.
    Martina V; Bruno GA; Trucco F; Zumpano E; Tagliabue M; Di Bisceglie C; Pescarmona G
    Thromb Haemost; 1998 Mar; 79(3):520-2. PubMed ID: 9531033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet function tests with clinical significance].
    Vicente García V
    Sangre (Barc); 1984; 29(4-C):783-97. PubMed ID: 6515513
    [No Abstract]   [Full Text] [Related]  

  • 8. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus.
    Jenkins AJ; Gosmanova AK; Lyons TJ; May KD; Dashti A; Baker MZ; Olansky L; Aston CE; Dale GL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):e8-10. PubMed ID: 18508150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.
    Vitkovsky Y; Kuznik B; Solpov A; Magen E
    Isr Med Assoc J; 2008 Oct; 10(10):691-4. PubMed ID: 19009947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased vascular prostacyclin in juvenile-onset diabetes.
    Silberbauer K; Schernthaner G; Sinzinger H; Piza-Katzer H; Winter M
    N Engl J Med; 1979 Feb; 300(7):366-7. PubMed ID: 366410
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
    Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet adhesiveness in juvenile onset and maturity onset diabetes mellitus.
    Sharma SC
    Thromb Haemost; 1981 Jun; 45(3):297. PubMed ID: 7281109
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM.
    Hilberg T; Eichler E; Gläser D; Schmidt V; Gabriel HH
    Platelets; 2004 Mar; 15(2):101-8. PubMed ID: 15154602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin sensitivity of platelet aggregation in diabetes mellitus.
    Albert SG; Hasnain BI; Ritter DG; Joist JH; Mooradian AD
    Diabetes Res Clin Pract; 2005 Nov; 70(2):195-9. PubMed ID: 15894396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet aggregation in insulin-dependent diabetics].
    González MA
    Acta Med Port; 1981; 3(4):261-5. PubMed ID: 7331883
    [No Abstract]   [Full Text] [Related]  

  • 18. Adhesion, spreading, and aggregation of platelets in flowing blood and the reliability of the retention test Homburg.
    Krischek B; Morgenstern E; Mestres P; Klinkhardt U; Brannath W; Wieding U; Nemeh A; Heinrich W; Schenk J; Wenzel T; Wenzel E
    Semin Thromb Hemost; 2005; 31(4):449-57. PubMed ID: 16149023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules.
    Tailor A; Granger DN
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):675-80. PubMed ID: 12615684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.